Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01331616
Title Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors West Penn Allegheny Health System
Indications
Therapies
Age Groups: adult
Covered Countries

Facility Status City State Zip Country Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field